Skip to main content
. 2015 Oct 15;8(10):19212–19222.

Table 1.

Characteristics of subjects by eGFR (mL/min/1.73 m2) status (n=3876)

All eGFR ≥60 eGFR <60 p value
Men
    n 2260 (100) 1892 (83.7) 368 (16.3)
    Age (years) 51.8±12.2 49.6±11.3 63.4±9.9 <0.001
    BMI (kg/m2) 24.5±3.2 24.5±3.2 24.7±3.0 0.33
    Systolic BP (mmHg) 123±18 122±17 130±20 <0.001
    Diastolic BP (mmHg) 77±12 76±11 79±12 <0.001
    Fasting glucose (mmol/L) 5.22 (4.89-5.72) 5.22 (4.89-5.67) 5.33 (4.94-5.78) 0.09
    Total cholesterol (mmol/L) 5.05±0.94 5.05±0.94 5.09±0.92 0.47
    Triglyceride (mmol/L) 1.32 (0.90-1.93) 1.33 (0.90-1.95) 1.28 (0.88-1.80) 0.21
    HDL-C (mmol/L) 1.34±0.34 1.35±0.33 1.33±0.37 0.42
    AST (U/L) 23 (20-29) 23 (20-29) 24 (20-29) 0.78
    ALT (U/L) 25 (19-37) 26 (19-38) 23 (17-32) <0.001
    Creatinine (μmol/L) 103.7±22.9 98.3±10.9 131.4±41.1 <0.001
    Uric acid (μmol/L) 416.3±93.0 410.0±91.2 448.4±95.4 <0.001
    Previous stroke 16 (0.7) 8 (0.4) 8 (2.2) 0.002
    Previous myocardial infarction 43 (1.9) 29 (1.5) 14 (3.8) 0.007
    Medication for hypertension 317 (14.0) 207 (10.9) 110 (29.9) <0.001
    Medication for diabetes 108 (4.8) 94 (5.0) 14 (3.8) 0.41
    Medication for hyperlipidemia 54 (2.4) 41 (2.2) 13 (3.5) 0.17
    Medication for hyperuricemia 73 (3.2) 39 (2.1) 34 (9.2) <0.001
    Analgesics 48 (2.1) 36 (1.9) 12 (3.3) 0.15
    Smoking* 725 (34.3) 642 (36.0) 83 (24.9) <0.001
    Habitual alcohol consumption* 447 (22.5) 399 (23.6) 48 (16.4) 0.009
    Total bilirubin (μmol/L) 14.63±6.61 14.77±6.58 13.88±6.70 0.02
Women
    n 1616 (100) 1465 (90.7) 151 (9.3)
    Age (years) 49.3±11.8 48.0±11.3 61.5±8.8 <0.001
    BMI (kg/m2) 23.4±3.4 23.3±3.3 24.8±3.8 <0.001
    Systolic BP (mmHg) 119±19 117±18 135±24 <0.001
    Diastolic BP (mmHg) 73±12 73±11 79±12 <0.001
    Fasting glucose (mmol/L) 5.06 (4.78-5.44) 5.06 (4.72-5.44) 5.22 (4.94-5.72) <0.001
    Total cholesterol (mmol/L) 5.02±0.93 4.98±0.91 5.31±1.02 <0.001
    Triglyceride (mmol/L) 0.95 (0.68-1.44) 0.93 (0.67-1.39) 1.37 (0.86-1.89) <0.001
    HDL-C (mmol/L) 1.64±0.40 1.65±0.40 1.57±0.42 0.03
    AST (U/L) 20 (17-24) 20 (17-24) 22 (19-29) <0.001
    ALT (U/L) 17 (13-24) 17 (13-24) 19 (15-28) 0.01
    Creatinine (μmol/L) 78.8±37.8 74.3±9.0 122.5±111.6 <0.001
    Uric acid (μmol/L) 322.2±79.2 314.8±74.0 395.0±91.5 <0.001
    Previous stroke 10 (0.6) 5 (0.3) 5 (3.3) 0.001
    Previous myocardial infarction 12 (0.7) 8 (0.5) 4 (2.6) 0.02
    Medication for hypertension 175 (10.8) 121 (8.3) 54 (35.8) <0.001
    Medication for diabetes 45 (2.8) 30 (2.0) 15 (9.9) <0.001
    Medication for hyperlipidemia 18 (1.1) 13 (0.9) 5 (3.3) 0.02
    Medication for hyperuricemia 11 (0.7) 5 (0.3) 6 (4.0) <0.001
    Analgesics 54 (3.3) 48 (3.3) 6 (4.0) 0.82
    Smoking* 66 (4.6) 64 (4.9) 2 (1.6) 0.14
    Habitual alcohol consumption* 46 (3.7) 45 (3.9) 1 (1.0) 0.17
    Total bilirubin (μmol/L) 11.42±5.08 11.53±5.02 10.41±5.55 0.01

Values are expressed as mean ± standard deviation, median (interquartile range) and number (percentage). BMI, body mass index; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol. AST, aspartate aminotransferase; ALT, alanine aminotransferase. p values were determined by chi-square analysis, unpaired t-test or Mann-Whitney U test.

*

Some data on smoking (n=341, M:F=145:196) and alcohol consumption (n=633, M:F=277:356) were missing.